A study of 346 patients with germline DDX41 mutations reported that MDS patients with truncating variants of DDX41 germline mutations were observed to have shorter duration to AML transformation, about 2.5 times faster, compared to patients with non-truncating variants [37]. The gene discussed is DDX41; the disease is acute myeloid leukemia.